|
GB796524A
(en)
|
1956-03-21 |
1958-06-11 |
Hickson & Welch Ltd |
Improvements in or relating to optical whitening agents
|
|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
|
US4270537A
(en)
|
1979-11-19 |
1981-06-02 |
Romaine Richard A |
Automatic hypodermic syringe
|
|
AU570021B2
(en)
|
1982-11-22 |
1988-03-03 |
Novartis Ag |
Analogs of mevalolactone
|
|
US4828991A
(en)
|
1984-01-31 |
1989-05-09 |
Akzo N.V. |
Tumor specific monoclonal antibodies
|
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
|
CA1283827C
(en)
|
1986-12-18 |
1991-05-07 |
Giorgio Cirelli |
Appliance for injection of liquid formulations
|
|
GB8704027D0
(en)
|
1987-02-20 |
1987-03-25 |
Owen Mumford Ltd |
Syringe needle combination
|
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
|
US4940460A
(en)
|
1987-06-19 |
1990-07-10 |
Bioject, Inc. |
Patient-fillable and non-invasive hypodermic injection device assembly
|
|
US4782084A
(en)
|
1987-06-29 |
1988-11-01 |
Merck & Co., Inc. |
HMG-COA reductase inhibitors
|
|
US4885314A
(en)
|
1987-06-29 |
1989-12-05 |
Merck & Co., Inc. |
Novel HMG-CoA reductase inhibitors
|
|
US5339163A
(en)
|
1988-03-16 |
1994-08-16 |
Canon Kabushiki Kaisha |
Automatic exposure control device using plural image plane detection areas
|
|
FR2638359A1
(fr)
|
1988-11-03 |
1990-05-04 |
Tino Dalto |
Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
|
US5420245A
(en)
|
1990-04-18 |
1995-05-30 |
Board Of Regents, The University Of Texas |
Tetrapeptide-based inhibitors of farnesyl transferase
|
|
US5190521A
(en)
|
1990-08-22 |
1993-03-02 |
Tecnol Medical Products, Inc. |
Apparatus and method for raising a skin wheal and anesthetizing skin
|
|
US5527288A
(en)
|
1990-12-13 |
1996-06-18 |
Elan Medical Technologies Limited |
Intradermal drug delivery device and method for intradermal delivery of drugs
|
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
|
GB9118204D0
(en)
|
1991-08-23 |
1991-10-09 |
Weston Terence E |
Needle-less injector
|
|
SE9102652D0
(sv)
|
1991-09-13 |
1991-09-13 |
Kabi Pharmacia Ab |
Injection needle arrangement
|
|
US5328483A
(en)
|
1992-02-27 |
1994-07-12 |
Jacoby Richard M |
Intradermal injection device with medication and needle guard
|
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
US5569189A
(en)
|
1992-09-28 |
1996-10-29 |
Equidyne Systems, Inc. |
hypodermic jet injector
|
|
US5334144A
(en)
|
1992-10-30 |
1994-08-02 |
Becton, Dickinson And Company |
Single use disposable needleless injector
|
|
EP0604181A1
(en)
|
1992-12-21 |
1994-06-29 |
Eli Lilly And Company |
Antitumor compositions and method of treatment
|
|
WO1994019357A1
(en)
|
1993-02-23 |
1994-09-01 |
Merrell Dow Pharmaceuticals Inc. |
Farnesyl:protein transferase inhibitors as anticancer agents
|
|
CA2118985A1
(en)
|
1993-04-02 |
1994-10-03 |
Dinesh V. Patel |
Heterocyclic inhibitors of farnesyl protein transferase
|
|
EP0698015A1
(en)
|
1993-05-14 |
1996-02-28 |
Genentech, Inc. |
Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole
|
|
US5602098A
(en)
|
1993-05-18 |
1997-02-11 |
University Of Pittsburgh |
Inhibition of farnesyltransferase
|
|
WO1995008542A1
(en)
|
1993-09-22 |
1995-03-30 |
Kyowa Hakko Kogyo Co., Ltd. |
Farnesyltransferase inhibitor
|
|
IL111235A
(en)
|
1993-10-15 |
2001-03-19 |
Schering Plough Corp |
Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
|
|
US5719148A
(en)
|
1993-10-15 |
1998-02-17 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
US5661152A
(en)
|
1993-10-15 |
1997-08-26 |
Schering Corporation |
Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
IL111257A0
(en)
|
1993-10-15 |
1994-12-29 |
Schering Corp |
Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
US5721236A
(en)
|
1993-10-15 |
1998-02-24 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
ATE210652T1
(de)
|
1993-10-15 |
2001-12-15 |
Schering Corp |
Tricyclische carbamat-derivate zur inhibierung der g-protein funktion und für die behandlung von proliferativen erkrankungen
|
|
AU682906B2
(en)
|
1993-10-25 |
1997-10-23 |
Parke, Davis & Company |
Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
|
|
US5783593A
(en)
|
1993-11-04 |
1998-07-21 |
Abbott Laboratories |
Inhibitors of squalene synthetase and protein farnesyltransferase
|
|
CA2152822A1
(en)
|
1993-11-04 |
1995-05-11 |
William R. Baker |
Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
|
|
EP0730605A1
(en)
|
1993-11-05 |
1996-09-11 |
Warner-Lambert Company |
Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
|
|
US5484799A
(en)
|
1993-12-09 |
1996-01-16 |
Abbott Laboratories |
Antifungal dorrigocin derivatives
|
|
WO1995024176A1
(en)
|
1994-03-07 |
1995-09-14 |
Bioject, Inc. |
Ampule filling device
|
|
US5466220A
(en)
|
1994-03-08 |
1995-11-14 |
Bioject, Inc. |
Drug vial mixing and transfer device
|
|
FI963597L
(fi)
|
1994-03-15 |
1996-11-14 |
Eisai Co Ltd |
Isoprenyylitransferaasi-inhibiittoreita
|
|
HUT72440A
(en)
|
1994-03-31 |
1996-04-29 |
Bristol Myers Squibb Co |
Imidazole-containing inhibitors of farnesyl protein transferase and pharmaceutical compositions containing them
|
|
US5523430A
(en)
|
1994-04-14 |
1996-06-04 |
Bristol-Myers Squibb Company |
Protein farnesyl transferase inhibitors
|
|
US5510510A
(en)
|
1994-05-10 |
1996-04-23 |
Bristol-Meyers Squibb Company |
Inhibitors of farnesyl protein transferase
|
|
TW365602B
(en)
|
1994-06-10 |
1999-08-01 |
Rhone Poulenc Rorer Sa |
New farnesyl transferase inhibitors, their preparation and the pharmaceutical compositions which contain them
|
|
US5571792A
(en)
|
1994-06-30 |
1996-11-05 |
Warner-Lambert Company |
Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
|
|
WO1996005168A1
(en)
|
1994-08-11 |
1996-02-22 |
Banyu Pharmaceutical Co., Ltd. |
Substituted amide derivative
|
|
CA2155448A1
(en)
|
1994-08-11 |
1996-02-12 |
Katerina Leftheris |
Inhibitors of farnesyl protein transferase
|
|
EP0805154A1
(en)
|
1994-08-12 |
1997-11-05 |
Banyu Pharmaceutical Co., Ltd. |
N,n-disubstituted amic acid derivative
|
|
WO1996017861A1
(en)
|
1994-12-09 |
1996-06-13 |
Warner-Lambert Company |
Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase
|
|
US5599302A
(en)
|
1995-01-09 |
1997-02-04 |
Medi-Ject Corporation |
Medical injection system and method, gas spring thereof and launching device using gas spring
|
|
WO1996021456A1
(en)
|
1995-01-12 |
1996-07-18 |
University Of Pittsburgh |
Inhibitors of prenyl transferases
|
|
FR2729390A1
(fr)
|
1995-01-18 |
1996-07-19 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2730491B1
(fr)
|
1995-02-09 |
1997-03-14 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5684013A
(en)
|
1995-03-24 |
1997-11-04 |
Schering Corporation |
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
|
US5700806A
(en)
|
1995-03-24 |
1997-12-23 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
|
IL117798A
(en)
|
1995-04-07 |
2001-11-25 |
Schering Plough Corp |
Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
|
|
US5891872A
(en)
|
1995-04-07 |
1999-04-06 |
Schering Corporation |
Tricyclic compounds
|
|
US5712280A
(en)
|
1995-04-07 |
1998-01-27 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
|
EP0820452B1
(en)
|
1995-04-07 |
2003-06-04 |
Schering Corporation |
Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
|
|
US5831115A
(en)
|
1995-04-21 |
1998-11-03 |
Abbott Laboratories |
Inhibitors of squalene synthase and protein farnesyltransferase
|
|
IL118101A0
(en)
|
1995-05-03 |
1996-09-12 |
Abbott Lab |
Inhibitors of farnesyltransferase
|
|
US5919780A
(en)
|
1995-06-16 |
1999-07-06 |
Warner Lambert Company |
Tricyclic inhibitors of protein farnesyltransferase
|
|
FR2736641B1
(fr)
|
1995-07-10 |
1997-08-22 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
FR2736638B1
(fr)
|
1995-07-12 |
1997-08-22 |
Rhone Poulenc Rorer Sa |
Nouveaux inhibiteurs de farnesyl transferase, leur preparation et les compositions pharmaceutiques qui les contiennent
|
|
CH690163A5
(fr)
|
1995-07-28 |
2000-05-31 |
Symphar Sa |
Dérivés gem-diphosphonates substitués utiles en tant qu'agents anti-cancers.
|
|
DK0873123T3
(da)
|
1995-11-06 |
2003-08-04 |
Univ Pittsburgh |
Inhibitorer af protein-isoprenyltransferaser
|
|
WO1997017329A1
(en)
|
1995-11-07 |
1997-05-15 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same
|
|
WO1997018813A1
(en)
|
1995-11-22 |
1997-05-29 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
SK283335B6
(sk)
|
1995-12-08 |
2003-06-03 |
Janssen Pharmaceutica N. V. |
(Imidazol-5-yl)metyl-2-chinolinónové deriváty, spôsob a medziprodukty na ich prípravu, ich použitie a farmaceutické kompozície na ich báze
|
|
MY119007A
(en)
|
1995-12-22 |
2005-03-31 |
Schering Corp |
Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases.
|
|
US5893397A
(en)
|
1996-01-12 |
1999-04-13 |
Bioject Inc. |
Medication vial/syringe liquid-transfer apparatus
|
|
AU1529997A
(en)
|
1996-01-16 |
1997-08-11 |
Warner-Lambert Company |
Substituted histidine inhibitors of protein farnesyltransferase
|
|
US6673927B2
(en)
|
1996-02-16 |
2004-01-06 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
Farnesyl transferase inhibitors
|
|
EP0944388A4
(en)
|
1996-04-03 |
2001-08-16 |
Merck & Co Inc |
INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
|
|
IL126833A0
(en)
|
1996-05-22 |
1999-08-17 |
Warner Lambert Co |
Inhibitors of protein farnesyl transferase
|
|
EP0918771A4
(en)
|
1996-07-15 |
2001-02-07 |
Bristol Myers Squibb Co |
THIADIOXOBENZODIAZEPINES FOR USE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS
|
|
EP1003374A4
(en)
|
1996-12-30 |
2000-05-31 |
Merck & Co Inc |
INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
|
|
EP0951285A1
(en)
|
1996-12-30 |
1999-10-27 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5993412A
(en)
|
1997-05-19 |
1999-11-30 |
Bioject, Inc. |
Injection apparatus
|
|
US6214852B1
(en)
|
1998-10-21 |
2001-04-10 |
Bristol-Myers Squibb Company |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
|
GB9904387D0
(en)
|
1999-02-25 |
1999-04-21 |
Pharmacia & Upjohn Spa |
Antitumour synergistic composition
|
|
EP1187633A4
(en)
|
1999-04-08 |
2005-05-11 |
Arch Dev Corp |
USE OF ANTI-VEGF ANTIBODIES TO ENHANCE RADIATION IN ANTICANCER THERAPY
|
|
WO2001000207A1
(en)
|
1999-06-30 |
2001-01-04 |
Merck & Co., Inc. |
Src kinase inhibitor compounds
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
IL148718A0
(en)
|
1999-09-17 |
2002-09-12 |
Abbott Gmbh & Co Kg |
Pyrazolopyrimidines as therapeutic agents
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
KR100904157B1
(ko)
*
|
2000-08-10 |
2009-06-23 |
파마시아 이탈리아 에스.피.에이. |
키나제 억제제로서 활성인 비사이클로-피라졸, 이의제조방법 및 이를 포함하는 약제학적 조성물
|
|
US7429599B2
(en)
|
2000-12-06 |
2008-09-30 |
Signal Pharmaceuticals, Llc |
Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
|
|
HUP0400639A3
(en)
|
2000-12-21 |
2010-03-29 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors and pharmaceutical compositions containing them
|
|
FR2818642B1
(fr)
|
2000-12-26 |
2005-07-15 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
|
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
|
EP1373257B9
(en)
|
2001-03-29 |
2008-10-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
|
EP1401469A2
(en)
|
2001-04-09 |
2004-03-31 |
Lorantis Limited |
Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
|
|
US6881737B2
(en)
|
2001-04-11 |
2005-04-19 |
Amgen Inc. |
Substituted triazinyl acrylamide derivatives and methods of use
|
|
JP4523271B2
(ja)
|
2001-06-01 |
2010-08-11 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なチアゾール化合物
|
|
US6825190B2
(en)
|
2001-06-15 |
2004-11-30 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
|
WO2003026665A1
(en)
|
2001-09-26 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
|
|
WO2003051847A1
(en)
|
2001-12-19 |
2003-06-26 |
Smithkline Beecham P.L.C. |
(1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors
|
|
FR2836915B1
(fr)
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
EP1506176B1
(en)
|
2002-05-17 |
2013-04-24 |
Pfizer Italia S.r.l. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
WO2004005283A1
(en)
|
2002-07-09 |
2004-01-15 |
Vertex Pharmaceuticals Incorporated |
Imidazoles, oxazoles and thiazoles with protein kinase inhibiting activities
|
|
TWI329112B
(en)
|
2002-07-19 |
2010-08-21 |
Bristol Myers Squibb Co |
Novel inhibitors of kinases
|
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
|
DE10239042A1
(de)
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
|
CN1701073B
(zh)
|
2002-09-04 |
2011-06-22 |
先灵公司 |
作为细胞周期蛋白依赖激酶抑制剂的吡唑并[1,5-a]嘧啶
|
|
US7119200B2
(en)
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
CN100376580C
(zh)
|
2002-09-04 |
2008-03-26 |
先灵公司 |
作为细胞周期蛋白依赖性激酶抑制剂的吡唑并嘧啶
|
|
US20050250837A1
(en)
|
2002-10-18 |
2005-11-10 |
D Mello Santosh R |
Use of C-Raf inhibitors for the treatment of neurodegenerative diseases
|
|
AU2003278088A1
(en)
|
2002-10-28 |
2004-05-25 |
Bayer Healthcare Ag |
Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
|
|
UA81790C2
(uk)
|
2002-12-19 |
2008-02-11 |
Фармация Италия С.П.А. |
Заміщені піролопіразольні похідні як інгібітори кінази
|
|
FR2850022B1
(fr)
|
2003-01-22 |
2006-09-08 |
Centre Nat Rech Scient |
Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications
|
|
ATE479667T1
(de)
|
2003-02-06 |
2010-09-15 |
Bristol Myers Squibb Co |
Als kinaseinhibitoren geeignete verbindungen auf thiazolylbasis
|
|
GB0304665D0
(en)
|
2003-02-28 |
2003-04-02 |
Teijin Ltd |
Compounds
|
|
GB0305142D0
(en)
|
2003-03-06 |
2003-04-09 |
Eisai London Res Lab Ltd |
Synthesis
|
|
GB0305559D0
(en)
|
2003-03-11 |
2003-04-16 |
Teijin Ltd |
Compounds
|
|
DE602004014117D1
(de)
|
2003-03-25 |
2008-07-10 |
Vertex Pharma |
Thiazole zur verwendung als inhibitoren von protein-kinasen
|
|
US20050008640A1
(en)
|
2003-04-23 |
2005-01-13 |
Wendy Waegell |
Method of treating transplant rejection
|
|
CN1826324B
(zh)
|
2003-05-22 |
2011-12-07 |
雅培制药有限公司 |
吲唑、苯并异*唑和苯并异噻唑激酶抑制剂
|
|
SE0301906D0
(sv)
|
2003-06-26 |
2003-06-26 |
Astrazeneca Ab |
New compounds
|
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
NZ544756A
(en)
|
2003-07-22 |
2009-09-25 |
Astex Therapeutics Ltd |
3,4-Disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
US7442698B2
(en)
|
2003-07-24 |
2008-10-28 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
|
BRPI0413005A
(pt)
|
2003-07-29 |
2006-09-26 |
Irm Llc |
compostos e composições como inibidores da proteìna cinase
|
|
BR122019017579B8
(pt)
|
2003-08-15 |
2021-07-27 |
Novartis Ag |
2,4-pirimidinadiaminas, seus usos, combinação e composição farmacêutica
|
|
US20050130974A1
(en)
|
2003-10-17 |
2005-06-16 |
Rigel Pharmaceuticals, Inc. |
Benzothiazole compositions and their use as ubiquitin ligase inhibitors
|
|
WO2005037797A1
(en)
|
2003-10-21 |
2005-04-28 |
Pharmacia Corporation |
Substituted pyrazole urea compounds for the treatment of inflammation
|
|
DE10357510A1
(de)
|
2003-12-09 |
2005-07-07 |
Bayer Healthcare Ag |
Heteroarylsubstituierte Benzole
|
|
BRPI0418031A
(pt)
|
2003-12-22 |
2007-04-17 |
Gilead Sciences Inc |
inibidores de quinase fosfonato-substituìdos
|
|
DK1702917T3
(da)
|
2003-12-25 |
2017-11-13 |
Nippon Shinyaku Co Ltd |
Amidderivat og medicin
|
|
CN1960995B
(zh)
|
2004-04-02 |
2010-12-08 |
诺瓦提斯公司 |
作为葡糖激酶活化剂、可用于治疗ⅱ型糖尿病的磺酰胺-噻唑并吡啶衍生物
|
|
DE102004017438A1
(de)
|
2004-04-08 |
2005-11-03 |
Bayer Healthcare Ag |
Hetaryloxy-substituierte Phenylaminopyrimidine
|
|
US20050228031A1
(en)
|
2004-04-13 |
2005-10-13 |
Bilodeau Mark T |
Tyrosine kinase inhibitors
|
|
DE102004020570A1
(de)
|
2004-04-27 |
2005-11-24 |
Bayer Healthcare Ag |
Substituierte Phenylaminopyrimidine
|
|
GB0411791D0
(en)
|
2004-05-26 |
2004-06-30 |
Cyclacel Ltd |
Compounds
|
|
FR2871158A1
(fr)
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
|
CN1960988B
(zh)
|
2004-06-10 |
2012-01-25 |
Irm责任有限公司 |
作为蛋白激酶抑制剂的化合物和组合物
|
|
DE102004028862A1
(de)
|
2004-06-15 |
2005-12-29 |
Merck Patent Gmbh |
3-Aminoindazole
|
|
EP1789399A1
(en)
|
2004-08-31 |
2007-05-30 |
AstraZeneca AB |
Quinazolinone derivatives and their use as b-raf inhibitors
|
|
US20060100226A1
(en)
|
2004-09-10 |
2006-05-11 |
Sikorski James A |
2-Thiopyrimidinones as therapeutic agents
|
|
US7632854B2
(en)
|
2004-11-17 |
2009-12-15 |
Pfizer Italia S.R.L. |
Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
|
AU2005322855B2
(en)
|
2004-12-30 |
2012-09-20 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
|
SI1838718T1
(sl)
|
2005-01-10 |
2011-08-31 |
Pfizer |
Pirolopirazoli, zmogljivi inhibitorji kinaze
|
|
AR052559A1
(es)
|
2005-01-21 |
2007-03-21 |
Astex Therapeutics Ltd |
Derivados de pirazol para inhibir cdk's y gsk's
|
|
CN101106990B
(zh)
|
2005-01-26 |
2010-12-08 |
Irm责任有限公司 |
用作蛋白激酶抑制剂的化合物和组合物
|
|
TW200639163A
(en)
|
2005-02-04 |
2006-11-16 |
Genentech Inc |
RAF inhibitor compounds and methods
|
|
US20090156582A1
(en)
|
2005-02-09 |
2009-06-18 |
Tetsuya Tsukamoto |
Pyrazole Compound
|
|
DE102005008310A1
(de)
|
2005-02-17 |
2006-08-24 |
Schering Ag |
Verwendung von CDKII Inhibitoren zur Fertilitätskontrolle
|
|
AU2006247322A1
(en)
|
2005-05-16 |
2006-11-23 |
Irm Llc |
Pyrrolopyridine derivatives as protein kinase inhibitors
|
|
PL2395004T3
(pl)
|
2005-06-22 |
2016-08-31 |
Plexxikon Inc |
Pochodne pirolo[2,3-b]pirydyny jako inhibitory kinazy białkowej
|
|
AU2006283592A1
(en)
|
2005-08-22 |
2007-03-01 |
Amgen Inc. |
Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
|
|
US7880004B2
(en)
|
2005-09-15 |
2011-02-01 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
AU2006295645B2
(en)
|
2005-09-30 |
2011-09-29 |
Msd K.K. |
2-heteroaryl-substituted indole derivative
|
|
GT200600429A
(es)
|
2005-09-30 |
2007-04-30 |
|
Compuestos organicos
|
|
GB0520955D0
(en)
|
2005-10-14 |
2005-11-23 |
Cyclacel Ltd |
Compound
|
|
US8247556B2
(en)
|
2005-10-21 |
2012-08-21 |
Amgen Inc. |
Method for preparing 6-substituted-7-aza-indoles
|
|
MEP0808A
(xx)
|
2005-12-21 |
2010-02-10 |
Pfizer Prod Inc |
Karbonilamino pirolopirayoli, snažni inhibitori kinaza
|
|
JP5200939B2
(ja)
|
2005-12-23 |
2013-06-05 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
二環式ヘテロアリール化合物
|
|
WO2007076474A1
(en)
|
2005-12-23 |
2007-07-05 |
Kalypsys, Inc. |
Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases
|
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
|
KR20090019796A
(ko)
|
2006-05-22 |
2009-02-25 |
쉐링 코포레이션 |
ＣＤＫ 억제제로서의 피라졸로[1,5-ａ]피리미딘
|
|
JP2009538352A
(ja)
|
2006-05-26 |
2009-11-05 |
アストラゼネカ アクチボラグ |
細胞増殖を阻害するための薬剤としての２−カルボシクロアミノ−４−イミダゾリルピリミジン類
|
|
WO2008009954A1
(en)
|
2006-07-21 |
2008-01-24 |
Astex Therapeutics Limited |
Medical use of cyclin dependent kinases inhibitors
|
|
EP2471529A3
(en)
|
2006-09-05 |
2012-10-10 |
Emory University |
Kinase Inhibitors for Preventing or Treating Pathogen Infection and Method of Use Thereof
|
|
EA018573B1
(ru)
|
2006-09-22 |
2013-09-30 |
Фармасайкликс, Инк. |
Ингибиторы тирозинкиназы брутона
|
|
EP2089394B1
(en)
|
2006-10-11 |
2011-06-29 |
Nerviano Medical Sciences S.r.l. |
Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
|
|
WO2008054827A2
(en)
|
2006-11-03 |
2008-05-08 |
Pharmacyclics, Inc. |
Bruton's tyrosine kinase activity probe and method of using
|
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
|
JP5179509B2
(ja)
|
2006-12-08 |
2013-04-10 |
エフ．ホフマン−ラ ロシュ アーゲー |
置換ピリミジン類及びｊｎｋモジュレーターとしてのこれらの使用
|
|
ES2509820T3
(es)
|
2006-12-20 |
2014-10-20 |
Nerviano Medical Sciences S.R.L. |
Derivados de indazol como inhibidores de la cinasa para el tratamiento del cáncer
|
|
US7872018B2
(en)
|
2006-12-21 |
2011-01-18 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
JP5161245B2
(ja)
|
2007-02-07 |
2013-03-13 |
ファイザー・インク |
ＰＫＣ阻害剤としての３−アミノ−ピロロ［３，４−ｃ］ピラゾール−５（１Ｈ，４Ｈ，６Ｈ）カルボアルデヒド誘導体
|
|
JP5577104B2
(ja)
|
2007-03-14 |
2014-08-20 |
エクセリクシス パテント カンパニー エルエルシー |
ヘッジホッグ経路の阻害剤
|
|
WO2008124393A1
(en)
|
2007-04-04 |
2008-10-16 |
Irm Llc |
Benzothiazole derivatives and their use as protein kinase inhibitors
|
|
CA2683695C
(en)
|
2007-04-12 |
2013-06-18 |
Pfizer Inc. |
3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives
|
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
EP2152079A4
(en)
|
2007-06-04 |
2011-03-09 |
Avila Therapeutics Inc |
HETEROCYCLIC COMPOUNDS AND USES THEREOF
|
|
WO2008151304A1
(en)
|
2007-06-05 |
2008-12-11 |
Emory University |
Selective inhibitors for cyclin-dependent kinases
|
|
EA201000003A1
(ru)
|
2007-06-21 |
2010-06-30 |
Айрм Ллк |
Ингибиторы протеинкиназ и способы их применения
|
|
ES2401557T3
(es)
|
2007-08-02 |
2013-04-22 |
Amgen, Inc |
Moduladores de Pl3 cinasas y métodos de uso
|
|
US20090054392A1
(en)
|
2007-08-20 |
2009-02-26 |
Wyeth |
Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
|
WO2009032694A1
(en)
|
2007-08-28 |
2009-03-12 |
Dana Farber Cancer Institute |
Amino substituted pyrimidine, pyrollopyridine and pyrazolopyrimidine derivatives useful as kinase inhibitors and in treating proliferative disorders and diseases associated with angiogenesis
|
|
WO2009028655A1
(ja)
|
2007-08-30 |
2009-03-05 |
Takeda Pharmaceutical Company Limited |
複素環化合物およびその用途
|
|
KR100923540B1
(ko)
|
2007-11-23 |
2009-10-27 |
한국과학기술연구원 |
5-아실하이드라진카르보닐-3,4-디치환 피라졸 유도체 및이의 제조방법
|
|
EA201001456A1
(ru)
|
2008-03-21 |
2011-06-30 |
Новартис Аг |
Новые гетероциклические соединения и их применение
|
|
WO2009122180A1
(en)
|
2008-04-02 |
2009-10-08 |
Medical Research Council |
Pyrimidine derivatives capable of inhibiting one or more kinases
|
|
GB0806419D0
(en)
|
2008-04-09 |
2008-05-14 |
Ineos Fluor Holdings Ltd |
Process
|
|
US20100197688A1
(en)
|
2008-05-29 |
2010-08-05 |
Nantermet Philippe G |
Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
|
|
TWI490214B
(zh)
|
2008-05-30 |
2015-07-01 |
艾德克 上野股份有限公司 |
苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途
|
|
EP2300481B1
(en)
|
2008-05-30 |
2015-09-30 |
Merck Sharp & Dohme Corp. |
Novel substituted azabenzoxazoles
|
|
WO2009152027A1
(en)
|
2008-06-12 |
2009-12-17 |
Merck & Co., Inc. |
5,7-dihydro-6h-pyrrolo[2,3-d]pyrimidin-6-one derivatives for mark inhibition
|
|
WO2009155527A2
(en)
|
2008-06-19 |
2009-12-23 |
Progenics Pharmaceuticals, Inc. |
Phosphatidylinositol 3 kinase inhibitors
|
|
EP2311842A3
(en)
|
2008-06-24 |
2011-07-13 |
Takeda Pharmaceutical Company Limited |
PI3K/M TOR inhibitors
|
|
TWI450898B
(zh)
|
2008-07-04 |
2014-09-01 |
Sigma Tau Res Switzerland Sa |
具有抗腫瘤活性之芳基異唑化合物
|
|
NZ602832A
(en)
|
2008-07-14 |
2014-04-30 |
Gilead Sciences Inc |
Fused heterocyclic hdac inhibitor compounds
|
|
WO2010017047A1
(en)
|
2008-08-05 |
2010-02-11 |
Merck & Co., Inc. |
Therapeutic compounds
|
|
US8394818B2
(en)
|
2008-10-17 |
2013-03-12 |
Dana-Farber Cancer Institute, Inc. |
Soluble mTOR complexes and modulators thereof
|
|
CN101723936B
(zh)
|
2008-10-27 |
2014-01-15 |
上海睿星基因技术有限公司 |
激酶抑制剂及其在药学中的用途
|
|
CA2744713A1
(en)
|
2008-12-05 |
2010-06-10 |
Arqule, Inc. |
Raf inhibitors and their uses
|
|
WO2010075542A1
(en)
|
2008-12-23 |
2010-07-01 |
Curis, Inc. |
Cdk inhibitors
|
|
KR20110120286A
(ko)
|
2009-02-12 |
2011-11-03 |
아스텔라스세이야쿠 가부시키가이샤 |
헤테로환 유도체
|
|
JPWO2010125799A1
(ja)
|
2009-04-27 |
2012-10-25 |
塩野義製薬株式会社 |
Ｐｉ３ｋ阻害活性を有するウレア誘導体
|
|
JP5918693B2
(ja)
|
2009-05-05 |
2016-05-18 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
Ｅｇｆｒ阻害剤及び疾患の治療方法
|
|
WO2010144416A1
(en)
|
2009-06-08 |
2010-12-16 |
Gaeta Federico C A |
SUBSTITUTED PYRAZOLO [1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY
|
|
WO2010144909A1
(en)
|
2009-06-12 |
2010-12-16 |
Novartis Ag |
Fused heterocyclic compounds and their uses
|
|
FR2948367A1
(fr)
|
2009-07-24 |
2011-01-28 |
Centre Nat Rech Scient |
Derives d'acyl-guanidines modulateurs de la voie de signalisation des proteines hedgehog
|
|
US8586584B2
(en)
|
2009-10-14 |
2013-11-19 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
|
CN103080093A
(zh)
|
2010-03-16 |
2013-05-01 |
达纳－法伯癌症研究所公司 |
吲唑化合物及其应用
|
|
US8981083B2
(en)
|
2010-05-14 |
2015-03-17 |
Dana Farber Cancer Institute, Inc. |
Compositions and methods for treating neoplasia, inflammatory disease and other disorders
|
|
UY33539A
(es)
|
2010-08-02 |
2012-02-29 |
Astrazeneca Ab |
Compuestos químicos alk
|
|
CN102406646B
(zh)
|
2010-09-20 |
2015-09-09 |
北大方正集团有限公司 |
芳基脲衍生物用于制备治疗移植排斥药物的用途
|
|
CN102408408A
(zh)
|
2010-09-20 |
2012-04-11 |
北大方正集团有限公司 |
具有抗肿瘤作用的芳基脲衍生物
|
|
CN102406644A
(zh)
|
2010-09-20 |
2012-04-11 |
北大方正集团有限公司 |
芳基脲衍生物用于制备治疗移植排斥药物的新用途
|
|
US8546443B2
(en)
|
2010-12-21 |
2013-10-01 |
Boehringer Ingelheim International Gmbh |
Benzylic oxindole pyrimidines
|
|
CN103781780B
(zh)
|
2011-07-28 |
2015-11-25 |
赛尔佐姆有限公司 |
作为jak抑制剂的杂环基嘧啶类似物
|
|
WO2013040436A2
(en)
|
2011-09-16 |
2013-03-21 |
The Regents Of The University Of Michgian |
Esx-mediated transcription modulators and related methods
|
|
MD20140023A2
(ro)
|
2011-09-22 |
2014-06-30 |
Pfizer Inc. |
Derivaţi de pirolpirimidină şi purină
|
|
MX342746B
(es)
|
2011-09-28 |
2016-10-11 |
Euro-Celtique S A * |
Derivados de mostaza de nitrogeno.
|
|
CA2856291C
(en)
|
2011-11-17 |
2020-08-11 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
|
JP6353788B2
(ja)
|
2012-01-13 |
2018-07-04 |
エイシア バイオサイエンシーズ インコーポレイテッド |
抗がん剤としての複素環式化合物およびその使用
|
|
GB201204384D0
(en)
|
2012-03-13 |
2012-04-25 |
Univ Dundee |
Anti-flammatory agents
|
|
US9879003B2
(en)
|
2012-04-11 |
2018-01-30 |
Dana-Farber Cancer Institute, Inc. |
Host targeted inhibitors of dengue virus and other viruses
|
|
EP2870261B1
(en)
|
2012-07-09 |
2017-12-06 |
Novartis AG |
Biomarkers associated with cdk inhibitors
|
|
EP2909194A1
(en)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
US9758522B2
(en)
|
2012-10-19 |
2017-09-12 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
|
CN103319483B
(zh)
|
2012-10-19 |
2016-08-03 |
药源药物化学（上海）有限公司 |
一种利拉列汀重要中间体的制备方法
|
|
WO2014063054A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof
|
|
KR102212923B1
(ko)
|
2012-12-21 |
2021-02-04 |
플렉시콘 인코퍼레이티드 |
키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증
|
|
TW201444821A
(zh)
|
2013-03-13 |
2014-12-01 |
Janssen Pharmaceutica Nv |
經取代之哌啶化合物及其作為食慾素受體調節劑之用途
|
|
TWI621618B
(zh)
|
2013-03-13 |
2018-04-21 |
比利時商健生藥品公司 |
經取代２－氮雜雙環類及其作為食慾素受體調控劑之用途
|
|
US9938279B2
(en)
|
2013-04-09 |
2018-04-10 |
Energenesis Biomedical Co., Ltd |
Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)
|
|
CN103242341B
(zh)
|
2013-04-19 |
2015-12-09 |
中国科学院广州生物医药与健康研究院 |
噻吩并2，4取代嘧啶类化合物及其药物组合物与应用
|
|
CN104177363B
(zh)
|
2013-05-24 |
2018-06-05 |
江苏先声药业有限公司 |
双环杂环胺类Hedgehog信号通路抑制剂
|
|
AU2014287016B2
(en)
|
2013-07-11 |
2018-11-01 |
Acea Biosciences Inc. |
Pyrimidine derivatives as kinase inhibitors
|
|
BR112016001457A2
(pt)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
Inibidores de fatores de transcrição e usos dos mesmos
|
|
US10047070B2
(en)
|
2013-10-18 |
2018-08-14 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
|
|
AU2014337122B2
(en)
|
2013-10-18 |
2019-01-03 |
Dana-Farber Cancer Institute, Inc. |
Heteroaromatic compounds useful for the treatment of proliferative diseases
|
|
JP6879740B2
(ja)
|
2013-12-13 |
2021-06-02 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
リンパ形質細胞性リンパ腫を処置する方法
|
|
WO2015117087A1
(en)
|
2014-01-31 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
|
CN104860941B
(zh)
|
2014-02-25 |
2017-03-22 |
上海海雁医药科技有限公司 |
2,4‑二取代苯‑1,5‑二胺衍生物及其应用以及由其制备的药物组合物和药用组合物
|
|
LT3126352T
(lt)
|
2014-04-04 |
2019-01-10 |
Syros Pharmaceuticals, Inc. |
Nuo ciklino priklausomos kinazės 7 (cdk7) inhibitoriai
|
|
US10336760B2
(en)
|
2014-04-05 |
2019-07-02 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (CDK7)
|
|
US9862688B2
(en)
|
2014-04-23 |
2018-01-09 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
|
WO2015164614A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
|
CN104829610B
(zh)
|
2014-06-20 |
2017-03-15 |
中国科学院合肥物质科学研究院 |
一种新型布鲁顿酪氨酸激酶抑制剂
|
|
WO2016014542A1
(en)
|
2014-07-21 |
2016-01-28 |
Dana-Farber Cancer Institute, Inc. |
Imidazolyl kinase inhibitors and uses thereof
|
|
EP3172213B1
(en)
|
2014-07-21 |
2021-09-22 |
Dana-Farber Cancer Institute, Inc. |
Macrocyclic kinase inhibitors and uses thereof
|
|
US9878994B2
(en)
|
2014-07-24 |
2018-01-30 |
Beta Pharma Inc. |
2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof
|
|
CA2966164C
(en)
*
|
2014-10-31 |
2023-10-17 |
Ube Industries, Ltd. |
Substituted dihydropyrrolopyrazole compound
|
|
EP3236959B1
(en)
|
2014-12-23 |
2025-09-24 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
KR20170109546A
(ko)
|
2015-02-05 |
2017-09-29 |
메르크 파텐트 게엠베하 |
Irak1/4 억제제로서의 매크로시클릭 화합물 및 이들의 용도
|
|
AU2016243529B2
(en)
|
2015-03-27 |
2021-03-25 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
EP3302448B1
(en)
|
2015-06-04 |
2023-10-25 |
Aurigene Oncology Limited |
Substituted heterocyclyl derivatives as cdk inhibitors
|
|
US10702527B2
(en)
|
2015-06-12 |
2020-07-07 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
|
HK1254469A1
(zh)
|
2015-06-26 |
2019-07-19 |
Dana Farber Cancer Institute, Inc. |
稠合双环嘧啶衍生物及其用途
|
|
EP3313530B1
(en)
|
2015-06-26 |
2022-10-05 |
Dana Farber Cancer Institute, Inc. |
4,6-pyrimidinylene derivatives and uses thereof
|
|
EP4019515A1
(en)
|
2015-09-09 |
2022-06-29 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
|
WO2017160717A2
(en)
|
2016-03-15 |
2017-09-21 |
Memorial Sloan Kettering Cancer Center |
Method of treating diseases using kinase modulators
|
|
CA3041563C
(en)
|
2016-11-22 |
2023-10-31 |
Dana-Farber Cancer Institute, Inc. |
Pyrimidin-2-amine derivatives and pharmaceutical compositions thereof useful as inhibitors of cyclin-dependent kinase 12 (cdk12)
|
|
US10969394B2
(en)
|
2016-11-28 |
2021-04-06 |
Dana-Farber Cancer Institute, Inc. |
Reagents and methods for analysis of proteins and metabolites targeted by covalent probes
|
|
CN107235906B
(zh)
|
2017-06-28 |
2020-05-01 |
郑州大学第一附属医院 |
一组吡唑酰胺类衍生物及其应用
|
|
CN107686477B
(zh)
|
2017-09-30 |
2020-01-31 |
武汉九州钰民医药科技有限公司 |
作为cdk4/6抑制剂的新型化合物及其应用
|
|
JP7590185B2
(ja)
|
2018-06-25 |
2024-11-26 |
ダナ－ファーバー キャンサー インスティテュート， インコーポレイテッド |
Ｔａｉｒｅファミリーキナーゼインヒビターおよびそれらの使用
|
|
EP3885347B1
(en)
|
2018-11-14 |
2023-11-22 |
UBE Corporation |
Dihydropyrrolopyrazole derivative
|
|
CA3115126A1
(en)
|
2018-12-14 |
2020-06-18 |
Nathanael S. Gray |
Pyrazolopyridine inhibitors of c-jun-n-terminal kinases and uses thereof
|
|
AU2019413694B2
(en)
|
2018-12-28 |
2025-03-20 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 and uses thereof
|
|
CN113811324B
(zh)
|
2019-05-10 |
2024-09-24 |
达纳-法伯癌症研究公司 |
小分子局部黏着斑激酶(fak)抑制剂
|
|
AU2020319005B2
(en)
|
2019-07-23 |
2026-01-08 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 and uses thereof
|
|
JP7636388B2
(ja)
|
2019-08-05 |
2025-02-26 |
ダナ－ファーバー キャンサー インスティテュート，インコーポレイテッド |
サイクリン依存性キナーゼ７（ｃｄｋ７）の分解誘導剤およびその使用
|
|
AU2020414418A1
(en)
|
2019-12-24 |
2022-07-21 |
Dana-Farber Cancer Institute, Inc. |
The combination of cyclin dependent kinase 7 inhibitor and immunotherapy for treatment of cancer
|